Canada - English - Health Canada

wellspring pharmaceutical canada corp - octinoxate; octisalate; oxybenzone; avobenzone - lotion - 7.5%; 4.0%; 4.5%; 2.5% - octinoxate 7.5%; octisalate 4.0%; oxybenzone 4.5%; avobenzone 2.5% - sunscreen agents

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - miconazole nitrate 20 mg in 1 g - antifungal/antifúngico - proven clinically effective in the treatment of most athlete's foot, jock itch and ringworm / comprobado clínicamente para el tratamiento de la mayoría de los casos de pie de atleta, la sarna deportiva y la tiña - for effective relief of itching, scaling, burning and discomfort that can company these conditions / para el alivio efectivo de picazón, descamación, ardor y las molestias que pueden acompañar estas condiciones

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - phenoxybenzamine hydrochloride (unii: x1ieg24ohl) (phenoxybenzamine - unii:0ttz664r7z) - phenoxybenzamine hydrochloride 10 mg

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - benzalkonium chloride 0.13 g in 100 ml - first aid to help prevent bacterial contamination or skin infection, and for temporary relief of pain and itching associated with minor: - cuts - scrapes - burns - sunburn - skin irritations

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - dextrose, unspecified form (unii: iy9xdz35w2) (dextrose, unspecified form - unii:iy9xdz35w2), fructose (unii: 6yss42vsev) (fructose - unii:6yss42vsev), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn) - upset stomach reliever       

United States - English - NLM (National Library of Medicine)

wellstat therapeutics corporation - uridine triacetate (unii: 2wp61f175m) (uridine - unii:whi7hq7h85) - uridine triacetate 951 mg in 1 g - xuriden® is indicated in adult and pediatric patients for the treatment of hereditary orotic aciduria. none risk summary there are no available data on xuriden use in pregnant women to inform a drug-associated risk. when administered orally to pregnant rats during the period of organogenesis, uridine triacetate at doses similar to the maximum recommended human dose (mrhd) of 120 mg/kg per day was not teratogenic and did not produce adverse effects on embryo-fetal development [see data] . the background risk of major birth defects and miscarriage for the indicated population are unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. data animal data in an embryo-fetal development study, uridine triacetate was administered orally to pregnant rats during the period of organogenesis at doses up to 2000 mg/kg per day (about 2.7 times the maximum recommended human dose (mrhd) of 120

United States - English - NLM (National Library of Medicine)

wellstat therapeutics corporation - uridine triacetate (unii: 2wp61f175m) (uridine - unii:whi7hq7h85) - uridine triacetate 951 mg in 1 g - vistogard® is indicated for the emergency treatment of adult and pediatric patients: - following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or - who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration. limitations of use - vistogard is not recommended for the non-emergent treatment of adverse reactions associated with fluorouracil or capecitabine because it may diminish the efficacy of these drugs. - the safety and efficacy of vistogard initiated more than 96 hours following the end of fluorouracil or capecitabine administration have not been established. none. risk summary limited case reports of uridine triacetate use during pregnancy are insufficient to inform a drug-associated risk of birth defects and miscarriage. when adminis

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - triamterene 50 mg - dyrenium (triamterene) is indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. dyrenium may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. it also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. usage in pregnancy . the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. diuretics are indicated in pregnancy (however, see preca

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - aluminum hydroxide (unii: 5qb0t2iun0) (aluminum hydroxide - unii:5qb0t2iun0), magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838), dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4) - aluminum hydroxide 200 mg - active ingredients (in each tablet)                  purpose aluminum hydroxide dried gel 200 mg........................antacid magnesium hydroxide 200 mg....................................antacid simethicone 25 mg......................................................antigas relieves:

United States - English - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic prevents and treats nausea, vomiting or dizziness associated with motion sickness